GI
GAMMA Investing Portfolio holdings
AUM
$1.58B
1-Year Return
23.44%
This Quarter Return
+7.18%
1 Year Return
+23.44%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.01B
AUM Growth
+$275M
(+37%)
Cap. Flow
+$233M
Cap. Flow
% of AUM
23.09%
Top 10 Holdings %
Top 10 Hldgs %
24.16%
Holding
3,706
New
246
Increased
2,543
Reduced
446
Closed
131
Top Buys
| 1 |
Apple
AAPL
|
+$12.1M |
| 2 |
NVIDIA
NVDA
|
+$8.46M |
| 3 |
Microsoft
MSFT
|
+$7.58M |
| 4 |
Meta Platforms (Facebook)
META
|
+$3.72M |
| 5 |
Amazon
AMZN
|
+$3.58M |
Top Sells
Sector Composition
| 1 | Technology | 24.31% |
| 2 | Financials | 11.77% |
| 3 | Healthcare | 9.71% |
| 4 | Industrials | 7.9% |
| 5 | Consumer Discretionary | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
MannKind Corp
MNKD
$1.67B
| $2.88K | ﹤0.01% |
458
+378
| +473% | +$2.38K |
|
2627
Columbus McKinnon
CMCO
$427M
| $2.88K | ﹤0.01% |
80
+5
| +7% | +$180 |
|
|
NBIS
2628
Nebius Group N.V. Class A Ordinary Shares
NBIS
$21.3B
| $2.88K | ﹤0.01% |
152
| – | – |
|
2629
Soleno Therapeutics
SLNO
$3.01B
| $2.88K | ﹤0.01% |
+57
| New | +$2.88K |
|
2630
La-Z-Boy
LZB
$1.44B
| $2.88K | ﹤0.01% |
67
+27
| +68% | +$1.16K |
|
2631
RGC Resources
RGCO
$230M
| $2.87K | ﹤0.01% |
127
| – | – |
|
2632
Deluxe
DLX
$889M
| $2.87K | ﹤0.01% |
147
+48
| +48% | +$936 |
|
|
PRSU
2633
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.06B
| $2.83K | ﹤0.01% |
79
+3
| +4% | +$108 |
|
|
ENV
2634
DELISTED
ENVESTNET, INC.
ENV
| $2.82K | ﹤0.01% |
45
+14
| +45% | +$877 |
|
2635
AvidXchange
AVDX
$2.06B
| $2.81K | ﹤0.01% |
347
+88
| +34% | +$714 |
|
2636
Phathom Pharmaceuticals
PHAT
$854M
| $2.78K | ﹤0.01% |
154
+147
| +2,100% | +$2.66K |
|
2637
South Plains Financial
SPFI
$651M
| $2.78K | ﹤0.01% |
82
+36
| +78% | +$1.22K |
|
2638
ARKO Corp
ARKO
$585M
| $2.77K | ﹤0.01% |
395
+173
| +78% | +$1.22K |
|
2639
Hudson Technologies
HDSN
$450M
| $2.77K | ﹤0.01% |
332
+181
| +120% | +$1.51K |
|
2640
Southern Missouri Bancorp
SMBC
$639M
| $2.77K | ﹤0.01% |
49
| – | – |
|
|
ITOS
2641
DELISTED
iTeos Therapeutics
ITOS
| $2.77K | ﹤0.01% |
271
+62
| +30% | +$633 |
|
2642
Western Union
WU
$2.74B
| $2.76K | ﹤0.01% |
231
+124
| +116% | +$1.48K |
|
|
DX
2643
Dynex Capital
DX
$1.63B
| $2.74K | ﹤0.01% |
215
+111
| +107% | +$1.42K |
|
2644
Argan
AGX
$3.21B
| $2.74K | ﹤0.01% |
27
+24
| +800% | +$2.44K |
|
2645
Deutsche Bank
DB
$71.4B
| $2.74K | ﹤0.01% |
158
+62
| +65% | +$1.07K |
|
2646
CRISPR Therapeutics
CRSP
$5.09B
| $2.73K | ﹤0.01% |
58
+3
| +5% | +$141 |
|
2647
Arcturus Therapeutics
ARCT
$490M
| $2.72K | ﹤0.01% |
117
-61
| -34% | -$1.42K |
|
2648
BCB Bancorp
BCBP
$153M
| $2.69K | ﹤0.01% |
218
+22
| +11% | +$271 |
|
2649
Avita Medical
RCEL
$118M
| $2.67K | ﹤0.01% |
249
+175
| +236% | +$1.88K |
|
2650
Fate Therapeutics
FATE
$116M
| $2.66K | ﹤0.01% |
761
| – | – |
|